XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net (loss) income $ (979) $ 5,047
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 19,820 20,275
Amortization of deferred financing costs 1,848 680
Credit loss expense 37 45
Deferred income tax benefit (2,056) (2,045)
Equity-based employee and director compensation expense 561 732
Loss on dispositions and lease terminations, net 1,767 244
Changes in operating assets and liabilities, net of acquisitions (9,460) 3,410
Net cash provided by operating activities 11,538 28,388
Cash flows from investing activities:    
Principal payments received on notes receivable 53 33
Proceeds from sale of assets 568 1,460
Capital expenditures (6,001) (8,934)
Cash paid in connection with acquisitions, net of cash acquired   (1,885)
Net cash used in investing activities (5,380) (9,326)
Cash flows from financing activities:    
Borrowings under revolving credit facilities 187,400 30,600
Repayments on revolving credit facilities (15,537) (26,575)
Borrowings under the Term Loan Facility   1,120
Repayments on the Term Loan Facility (158,980) (24,600)
Net proceeds from issuance of preferred membership interests   24,500
Payments of finance lease obligations (698) (658)
Payments of deferred financing costs (6,906) (6)
Distributions paid on distribution equivalent rights (56) (46)
Distributions paid on common units (19,918) (19,896)
Net cash provided used in financing activities (14,695) (15,561)
Net (decrease) increase in cash and cash equivalents (8,537) 3,501
Cash and cash equivalents at beginning of period 16,054 7,648
Cash and cash equivalents at end of period $ 7,517 $ 11,149